Fructose Linked to Ovarian Cancer Metastasis
Analysis based on 23 articles · First reported Jul 30, 2026 · Last updated Aug 12, 2026
The study could influence dietary recommendations for cancer patients and spur research into fructose metabolism inhibitors and repurposing diabetes drugs for oncology. It may also prompt scrutiny of statin use during chemotherapy, potentially affecting pharmaceutical markets for cholesterol-lowering drugs.
A study from Wistar Institute, published in List of Nature Research journals, reveals that ovarian cancer cells surviving chemotherapy release fructose, which signals neighboring cancer cells to detach and metastasize. The research, led by Katherine Aird and first author Aidan Cole, found that high dietary fructose, comparable to sugary drinks, can also promote spread even without chemotherapy. Using CRISPR screening, they discovered fructose suppresses cholesterol production, weakening cell adhesion. The findings raise questions about statins, which lower cholesterol and may similarly promote cancer cell escape, though the team stresses patients should not stop taking them. The study suggests potential interventions like limiting processed fructose and repurposing an anti-diabetic drug, but clinical confirmation is needed. The mechanism may extend to pancreatic, colon, and liver cancers. The research was a multi-institutional collaboration funded by NIH, American Cancer Society, and others.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard